FountainBlue produced an educational and thought-provoking FemTech Opportunities and Challenges program, in partnership with NEOME and hosted by Fenwick and West.
Thank you to our panelists, our presenting entrepreneurs, our hosts, our volunteers, and our attendees for their supporting in creating a powerhouse event, which covered everything from the market opportunity to the stories-from-the-trenches, from the funding details to the presenting companies with practical offerings in the market today. Below are some notes from the conversation.
It takes a village to put together such a powerhouse event, which covered everything from the market opportunity to the stories-from-the-trenches, from the funding details to the presenting companies with practical offerings in the market today.
Our attendees consistently remarked on the exceptional educational and practical value of the program, as well as the exceptional opportunity to meet each other and each of you. They each are thinking differently about the femtech opportunity and where they would each fit as entrepreneurs, as customers, as advocates, as professionals, as investors.
Below are some notes for your review and approval. Any comments are welcome.
We were fortunate to have such seasoned Femtech professionals on the panel, each speaking so authentically about the challenges they faced and the opportunities ahead around Femtech.
We launched the program by defining the femtech market and the opportunities and challenges ahead. Our panelists consistently remarked on the collaboration which take place around femtech investment, and also exclaimed on the great need in the market, plus the innovations available to address the needs of female patients.
We have obviously come far from the days decades ago when we knew so little about the female physiology, structure, biology – treating women like mini-men. But we have much farther to go to understand how to design and implement solutions which fully support the many opportunities around femtech.
Our panel agreed that many steps need to be taken to increase the number of start-ups and solutions.
- We need to increase the pipeline of men and women interested in learning the science and the technology and persistent enough to create solutions.
- We need to fund research around the many facets of femtech, prioritizing areas where there’s the greatest need, so that you can serve more people, and increase the likelihood of having a viable company.
- We need to translate the research into practical applications which can go to market, in a way which is practical, sustainable, affordable.
- We need to build companies and market these solutions – prove that there’s a market that’s willing to pay the price to sustain the company.
- We need to finance the companies which have proven there’s a viable and expanding market for the offering.
- Companies which are receiving funding need to execute on their plan and scale the operations which bring in the margins expected by investors, while also delivering the value demanded by their customers.
- Once the company is scaling and profitable and growing, and when it makes sense, successful exits will help bring further interest, further energy, further funding into the Femtech market.
Any of the steps above invite further collaboration. Any of our panelists and their organizations and peers would help leaders and companies and investors better contribute to femtech solutions at all levels.
We each applauded our presenting entrepreneurs offered us glimpses into the wide breadth of opportunities around FemTech. Please approach them directly for further information about how you can support their company as an investor, as an ambassador, as a contributor.
- Robert A. Feldman PhD, President and CEO, Prime Genomics, Inc – http://www.primegenomics.com
- Tracy MacNeal, President & CEO, Materna Medical – http://www.maternamedical.com
- Greta Meyer, co-founder and CEO, Tempo https://thisistempo.com/
- Claire Thomas, Founder and CEO, Tua Fertility http://tuafertility.com
- Soody Tronson, Founder and CEO, Presque http://www.mypresque.com/join/
The bottom line is that there’s an ecosystem of players, and we ALL need to support and encourage, through education and mentoring, scientists, especially women, so they can 1) conduct the research 2) translate that research into patents, and then 3) further help them envision, create and execute those patents into fundable companies.
We hope that this event helped you better understand this emerging business opportunity, and that you become more interested in participating in this Sheconomy, focusing on Femtech solutions and opportunities – in collaboration with the full ecosystem, to deliver tangible and immediate results.
Thursday, November 21, 5:30-8:00 p.m.
Location: Fenwick and West, 600 Castro Street, Mountain View
FemTech Opportunities and Challenges
See invitation and bios by visiting https://www.tikkl.com/fountainblue/c/worldchangers
Feminine health issues around everything from fertility to menstruation, from reproductive health to sexual wellness have arisen over the centuries. But in this age of information, the solutions involve integrated software and devices solutions which provide diagnostic and even curative support for female patients.
Our panel of activists and investors will profile the opportunities and challenges around FemTech and make predictions on what’s working now, what will work in the near future, plus advise us on how we can better collaborate to anticipate and address market needs.
- Facilitator Linda Holroyd, CEO, FountainBlue
- Panelist Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital
- Panelist Dr. Mitzi Krockover, Managing Director and Co-Chair Health Sector Committee, Golden Seed
- Panelist Nola E Masterson, Board Member, Professor, and Lead Investor in Portfolia FemTech Fund
- Panelist Einat Meisel, Partner, Head of Israel Practice, Fenwick & West
- with Keynote created by Reenita Das, SVP Healthcare, Frost and Sullivan
To wrap up the panel discussion, we will also profile several emerging femtech entrepreneurs for three minute presentations with three minutes of Q&A. Presenting Entrepreneurs included:
- Robert A. Feldman PhD, President and CEO, Prime Genomics, Inc
- Tracy MacNeal, President & CEO, Materna Medical
- Greta Meyer, co-founder and CEO, Tempo
- Claire Thomas, Founder and CEO, Tua Fertility
- Soody Tronson, Founder and CEO, Presque
You must be logged in to post a comment.